US RNA medicines company Arrowhead Pharmaceuticals (Nasdaq: ARWR) saw its shares rise about 19% after reporting positive top-line results from two pivotal Phase III studies of plozasiran in severe ...
A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the ...
UK gene therapy company EpilepsyGTx has named Teresa Nunes as its chief medical officer, tasking her with steering lead ...
USA-based gout specialist Crystalys Therapeutics has closed an oversubscribed $130 million series B financing to fund ...
Less than a month after a US advisory panel voted against it, AstraZeneca's (LSE: AZN) camizestrant has won a positive opinion from Europe's Committee for Medicinal Products for Human Use (CHMP), ...
A Nasdaq-listed biotech advancing bispecific antibodies that simultaneously block paired disease drivers in immunology and ...
US clinical-stage biotech Kairos Pharma saw its shares close down 12.6% at $0.31 yesterday, despite announcing a strategic ...
US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had ...
Cambridge Antibody Technology is the latest firm to join the Pfizer-Gen network of alliances, which Pfizer initiated in 1995 to expand its biotechnology expertise. As a result, CAT has signed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results